Hospital Pharmacy Europe

NOVEMBER 4, 2024

Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.

Chemotherapy 52

Chemotherapy Patient Care Clinic Management Hospitals 52

Hospital Pharmacy Europe

OCTOBER 14, 2024

With an introduction from Helena Beer, Dr Kunene shares first-hand insights into the clinical trial, the NHS Cancer Vaccine Launch Pad initiative and their potential for revolutionising patient care. Another treatment combination is chemotherapy with zolbetuximab – an antibody directed against claudin 18.6.

Vaccines 52

Vaccines Chemotherapy Hospitals Immunization 52

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Take this month to recognize their expertise and the valuable support they provide in patient care! Accessed June 6, 2023.

Health and Personal Care Stores 75

Health and Personal Care Stores Chemotherapy Immunization Compounding 75